Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The interferon regulatory factor 6 promotes cisplatin sensitivity in colorectal cancer. | Bioengineered | 2022 | 35443865 | PubTator, text mining | PubMed |
| Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas. | Sci Rep | 2022 | 35440701 | PubTator, text mining | PubMed |
| LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance. | Immunohorizons | 2022 | 35440514 | PubTator, text mining | PubMed |
| Interleukin-13 Receptor α1-Mediated Signaling Regulates Age-Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis. | Arthritis Rheumatol | 2022 | 35438841 | PubTator, text mining | PubMed |
| SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. | J Transl Autoimmun | 2022 | 35434592 | PubTator, text mining | PubMed |
| The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target. | Front Oncol | 2022 | 35433424 | PubTator, text mining | PubMed |
| Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation. | Front Immunol | 2022 | 35432323 | PubTator, text mining | PubMed |
| High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses. | Front Pharmacol | 2022 | 35431930 | PubTator, text mining | PubMed |
| The Pivotal Immunoregulatory Functions of Microglia and Macrophages in Glioma Pathogenesis and Therapy. | J Oncol | 2022 | 35419058 | PubTator, text mining | PubMed |
| A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes. | BMC Genomics | 2022 | 35418025 | PubTator, text mining | PubMed |
| Cisplatin resistance-related multi-omics differences and the establishment of machine learning models. | J Transl Med | 2022 | 35410350 | PubTator, text mining | PubMed |
| B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma. | BMC Cancer | 2022 | 35410157 | PubTator, text mining | PubMed |
| Myasthenia Gravis: An Acquired Interferonopathy? | Cells | 2022 | 35406782 | PubTator, text mining | PubMed |
| Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. | Nutrients | 2022 | 35406000 | PubTator, text mining | PubMed |
| Vitamin D and Its Target Genes. | Nutrients | 2022 | 35405966 | PubTator, text mining | PubMed |
| The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution. | Cancer Discov | 2022 | 35404441 | PubTator, text mining | PubMed |
| Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Noninflammatory Aortic Aneurysms. | Arthritis Rheumatol | 2022 | 35403833 | PubTator, text mining | PubMed |
| ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer. | Front Cell Dev Biol | 2022 | 35399517 | PubTator, text mining | PubMed |
| IRF4 suppresses osteogenic differentiation of BM-MSCs by transcriptionally activating miR-636/DOCK9 axis. | Clinics (Sao Paulo) | 2022 | 35397366 | PubTator, text mining | PubMed |
| Progression in translational research on spinal cord injury based on microenvironment imbalance. | Bone Res | 2022 | 35396505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=56